Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.56 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.56 |
| ▸ | NOTUM | Q6P988 | 5/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4324877 | 0.85 | ALDH1A1 (0.53) | ALDH1A1NPSR1NOTUMKMT2AKDM4E | |
| SCHEMBL12615992 | 0.83 | ALDH1A1 (0.68) | ALDH1A1NPSR1NOTUMKMT2AKDM4E | |
| SCHEMBL5549180 | 0.74 | ALDH1A1 (0.58) | ALDH1A1NPSR1NOTUMKMT2AKDM4E | |
| SCHEMBL436604 | 0.74 | ALDH1A1 (0.58) | ALDH1A1NPSR1NOTUMKMT2AKDM4E | |
| SCHEMBL30084182 | 0.74 | ALDH1A1 (0.58) | ALDH1A1NPSR1NOTUMKMT2AKDM4E | |
| SCHEMBL8109135 | 0.74 | ALDH1A1 (0.58) | ALDH1A1NPSR1NOTUMKMT2AKDM4E | |
| SCHEMBL5330184 | 0.74 | ALDH1A1 (0.58) | ALDH1A1NPSR1NOTUMKMT2AKDM4E | |
| SCHEMBL14242848 | 0.74 | ALDH1A1 (0.58) | ALDH1A1NPSR1NOTUMKMT2AKDM4E | |
| SCHEMBL8540440 | 0.74 | ALDH1A1 (0.58) | ALDH1A1NPSR1NOTUMKMT2AKDM4E | |
| SCHEMBL28955008 | 0.74 | ALDH1A1 (0.58) | ALDH1A1NPSR1NOTUMKMT2AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12629639-B2 | Spacer for a spiral wound membrane | EVOVE LTD (GB) | 2026-05-19 | — | — | US | disclosed |
| EP-4397399-A2 | MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES | G2O Water Technologies Limited (GB) | 2024-07-10 | — | — | EP | disclosed |
| US-20240157304-A1 | SPACER FOR A SPIRAL WOUND MEMBRANE | EVOVE LTD (GB) | 2024-05-16 | — | — | US | disclosed |
| US-20240149223-A1 | MEMBRANE DEVICE | EVOVE LTD (GB) | 2024-05-09 | — | — | US | disclosed |
| EP-4304765-A1 | SPACER FOR A SPIRAL WOUND MEMBRANE | Evove Ltd (GB) | 2024-01-17 | — | — | EP | disclosed |
| EP-4304766-A1 | MEMBRANE DEVICE | Evove Ltd (GB) | 2024-01-17 | — | — | EP | disclosed |
| WO-2022189793-A1 | MEMBRANE DEVICE | EVOVE LTD (GB) | 2022-09-15 | — | — | WO | disclosed |
| WO-2022189785-A1 | SPACER FOR A SPIRAL WOUND MEMBRANE | EVOVE LTD (GB) | 2022-09-15 | — | — | WO | disclosed |
| EP-3774001-A1 | MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES | G2O Water Technologies Limited (GB) | 2021-02-17 | — | — | EP | disclosed |
| US-20210016232-A1 | MEMBRANES COMPRISING A LAYER OF METAL ORGANIC FRAMEWORK PARTICLES | EVOVE LTD (GB) | 2021-01-21 | — | — | US | disclosed |
| US-9190114-B1 | Disk drive filter including fluorinated and non-fluorinated nanopourous organic framework materials | WESTERN DIGITAL TECHNOLOGIES, INC. (US) | 2015-11-17 | — | — | US | disclosed |
| US-7052783-B2 | Oxadiazole tetramers | ACADEMIA SINICA (TW) | 2006-05-30 | — | — | US | disclosed |
| US-20020102433-A1 | Oxadizaole tetramers | ACADEMIA SINICA (TW) | 2002-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629639-B2 | Spacer for a spiral wound membrane | AQP1, AQP3, AQP4 | ALDH1A1 1090/4885NPSR1 3455/4885NOTUM 4378/4885 |
| US-20020102433-A1 | Oxadizaole tetramers | NR4A1, NR0B1, NR0B2 | ALDH1A1 1330/4885NPSR1 282/4885NOTUM 1867/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.